PharmaCyte Biotech, Inc. (PMCB) stock
PMCBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30
$5.42−0.15 (-2.69%)
Close on Nov 17, 2026Market cap $58.19MP/E –Yield –
PharmaCyte Biotech market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
PharmaCyte Biotech's market cap was $4.28M on Nov 11, 2026, against $5.26M a year earlier. Over the last 5 years it ranged from $3.24M to $62.67M, with a median of $16.70M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $4.28M | -19.3% |
| 2025 | Dec 31, 2025 | $5.31M | -51.9% |
| 2024 | Dec 31, 2024 | $11.04M | -41.2% |
| 2023 | Dec 29, 2023 | $18.79M | -67.2% |
| 2022 | Dec 30, 2022 | $57.21M | +10.5% |
| 2021 | Dec 31, 2021 | $51.79M | +220.4% |
| 2020 | Dec 31, 2020 | $16.16M | -71.0% |
| 2019 | Dec 31, 2019 | $55.74M | +34.8% |
| 2018 | Dec 31, 2018 | $41.35M | -26.3% |
| 2017 | Dec 29, 2017 | $56.11M | -57.1% |
| 2016 | Dec 30, 2016 | $130.65M | +267.7% |
| 2015 | Dec 31, 2015 | $35.53M | -72.6% |
| 2014 | Dec 31, 2014 | $129.48M | +108.8% |
| 2013 | Dec 31, 2013 | $62.02M | – |
See a number that looks wrong?